IDS Launch Two Rapid Antigen Tests for COVID-19
We are pleased to announce that we are now able provide a range of rapid, point of care SARS-CoV-2 antigen tests. These tests detect patients who are currently infected with SARS-CoV-2, more commonly known as the COVID-19 virus:
Both rapid coronavirus tests have CE mark approval and can be performed by a trained healthcare professional in community locations (e.g. workplaces, schools, clinics, doctors’ surgeries) without the need for laboratory equipment. These antigen tests detect patients who are currently infected with the SARS-CoV-2 virus, providing a result within 15 minutes.
Both tests are performed on nasopharyngeal samples. In clinical comparison with PCR methods these tests have shown a sensitivity of 96% and 92% respectively, and a specificity of 99%.
The rapid tests join our existing COVID-19 portfolio, which includes, ELISA and fully automated laboratory-based SARS-CoV-2 antibody testing technologies, to help identify recent or historic infections.
To order our Rapid Antigen tests, or any of our COVID-19 portfolio, please contact your local Sales Representative or:
To order the Rapid Antigen tests, or for further information, please contact our UK Customer Service team:
|Test||Product Name||Format||Code||Product type||Unit size|
|COVID-19 Rapid Antigen Test: Cassette Format||Coronavirus Ag Rapid Test Cassette (Swab)||Lateral flow cassette with swab||GCCOV-502a||Manual||20 tests/kit|
|COVID-19 Rapid Antigen Test Card Format||SARS-CoV-2 Antigen Rapid Test Kit||Lateral flow card with swab||
N.B. This product is an in vitro diagnostic test the customer undertakes that only qualified healthcare professionals shall use the product.